Where Einstein Meets Edison

Biotechnology Innovation: Emerging Opportunities in the Biologics/Biosimilar Market in the U.S.

Biotechnology Innovation: Emerging Opportunities in the Biologics/Biosimilar Market in the U.S.

Aug 12, 2010

“Generics” is a common term in the prescription drug business lexicon. Although generics market (Gx Market) sales have generally soared in recent years, the Gx market is predominant in countries with high healthcare expenditures. For example, in the US, healthcare expenditures reached over $2.2tn in 2007, accounting for 16% of GDP. Prescription medication...